BioTissue
BioTissue is a regenerative medicine company and a university-hospital spin-off that develops and commercializes implantable scaffold technologies and autologous cell‑therapy grafts for orthobiology. Activities include scaffold design and fabrication, autologous chondrocyte culture and graft manufacturing, minimally invasive surgical delivery methods, and clinical outcome follow-up.
Industries
Nr. of Employees
small (1-50)
BioTissue
BioTissue SA, 5, Rue Paul-Bouchet, CH-1201 Genève
Patents
Compositions and methods for preventing the proliferation and epithelial-mesenchymal transition of epithelial cells
US-11318169-B2
View DetailsCompositions of morselized umbilical cord and/or amniotic membrane and methods of use thereof
US-11116800-B2
View Details
Compositions and methods for preventing the proliferation and epithelial-mesenchymal transition of epithelial cells
US-11318169-B2
View DetailsCompositions of morselized umbilical cord and/or amniotic membrane and methods of use thereof
US-11116800-B2
View DetailsProducts
Cell-free resorbable synthetic scaffold implant for cartilage repair
A mechanically stable, fully synthetic, cell-free resorbable three-dimensional scaffold implant intended to cover articular cartilage defects and support migration and retention of bone-marrow–derived cells following bone marrow stimulation procedures.
Autologous chondrocyte 3D graft in resorbable carrier
A form-stable, three-dimensional autologous chondrocyte transplant consisting of cultured patient chondrocytes embedded in a resorbable carrier matrix for implantation into cartilage defects.
Cell-free resorbable synthetic scaffold implant for cartilage repair
A mechanically stable, fully synthetic, cell-free resorbable three-dimensional scaffold implant intended to cover articular cartilage defects and support migration and retention of bone-marrow–derived cells following bone marrow stimulation procedures.
Autologous chondrocyte 3D graft in resorbable carrier
A form-stable, three-dimensional autologous chondrocyte transplant consisting of cultured patient chondrocytes embedded in a resorbable carrier matrix for implantation into cartilage defects.
Services
Contract and collaborative research and development services to advance scaffold materials, autologous cell‑therapy processes and clinical evaluation delivered via an affiliated development organization.
Contract and collaborative research and development services to advance scaffold materials, autologous cell‑therapy processes and clinical evaluation delivered via an affiliated development organization.
Expertise Areas
- Tissue engineering and autologous cell therapy
- Scaffold materials development for orthobiologics
- Orthobiology and cartilage repair
- Minimally invasive surgical implantation techniques
Key Technologies
- Autologous chondrocyte culture and 3D cell-seeded graft fabrication
- Synthetic resorbable porous scaffold fabrication
- High-interconnectivity porous scaffold design
- Arthroscopic and minimally invasive implant delivery techniques